Co-Authors
This is a "connection" page, showing publications co-authored by MYLENE TRUONG and MERRILL S KIES.
Connection Strength
0.039
-
A phase II study of Lonafarnib (SCH66336) in patients with chemorefractory, advanced squamous cell carcinoma of the head and neck. Am J Clin Oncol. 2009 Jun; 32(3):274-9.
Score: 0.021
-
Phase I dose escalation and pharmacokinetic study of enzastaurin, an oral protein kinase C beta inhibitor, in patients with advanced cancer. J Clin Oncol. 2006 Sep 01; 24(25):4092-9.
Score: 0.018